Analyst Reco. GlaxoSmithKline plc LIQUIDNET SYSTEMS

Equities

Delayed LIQUIDNET SYSTEMS Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-0.40%	-.--%

06-13	REGENXBIO Inc. Announces Chief Executive Officer Changes	CI
06-12	Moderna's RSV Vaccine Has 'Ample Opportunity' Despite Seasoned Competitors, Oppenheimer Says	MT

GSK : Goldman Sachs reaffirms its Neutral rating	06-10	ZD
GSK : JP Morgan maintains a Sell rating	06-07	ZD
HSBC Lifts GSK PT, Maintains Reduce Rating	06-05	MT
Berenberg raises Taylor Wimpey to 'buy'	06-05	AN
GSK : DZ Bank remains Neutral	06-04	ZD
GSK PLC : Frightened markets create an entry opportunity in GSK	06-04
GSK : Receives a Buy rating from UBS	06-04	ZD
GSK : Receives a Buy rating from Deutsche Bank	06-04	ZD
ANALYST RECOMMENDATIONS : Kinder Morgan, Marathon Petroleum, Autodesk, Cloudflare, Okta...	06-04
GSK : Buy rating from Jefferies	06-03	ZD
GSK : Sell rating from JP Morgan	06-03	ZD
GSK : Deutsche Bank reiterates its Buy rating	06-03	ZD
GSK : Goldman Sachs remains Neutral	06-03	ZD
Goldman Sachs Starts GSK With Neutral Rating, $47 Price Target	05-30	MT
Goldman Sachs Initiates GlaxoSmithKline with Neutral Rating	05-30	MT
Jefferies and UBS cut Anglo American	05-30	AN
GSK : Upgraded to Neutral by Goldman Sachs	05-30	ZD
GSK executive buys GBP20,026 worth shares	05-20	AN
GSK: FOLLOWING SETTLEMENT OF PLACING, GSK WILL HAVE FULLY EXITED…	05-17	RE
LBBW Raises GSK PT, Reiterates Buy Rating	05-14	MT

No results for this search

GSK PLC : Frightened markets create an entry opportunity in GSK

June 04, 2024 at 01:38 pm

GSK plc : Back on track

May 03, 2024 at 10:17 am